Dairy products and the risk to develop type 2 diabetes or cardiovascular disease

被引:17
|
作者
Mensink, Ronald P. [1 ]
机构
[1] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
关键词
dairy fat; CLA; human; metabolic syndrome;
D O I
10.1016/j.idairyj.2005.10.013
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Diet is important in the prevention and treatment of the metabolic syndrome, a cluster of metabolic risk markers, leading to type 2 diabetes and coronary heart disease (CHD). The aim of this review is to summarize recent findings from human studies on the effects of dairy products in this area. Epidemiological studies suggest a beneficial relationship between the consumption of low-fat dairy products and type 2 diabetes. For CHD, relationships are less consistent. These associations, however, do not prove causality, which can only be demonstrated by intervention studies. Several intervention trials have indeed shown positive effects on metabolic risk markers, of which dairy products were a part. The contribution of dairy products to the effects observed, however, is not known. Another important question is if dairy products contain a bioactive component that can explain these findings. In this respect, it is not likely that effects observed can be attributed to conjugated linoleic acid (CLA). (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 50 条
  • [1] Importance of Dairy Products in Cardiovascular Diseases and Type 2 Diabetes
    Yerlikaya, O.
    Acu, M.
    Kinik, O.
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2013, 53 (09) : 902 - 908
  • [2] Type 2 diabetes and cardiovascular disease: Reducing the risk
    Bartels, David W.
    Davidson, Michael H.
    Gong, William C.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (02): : S2 - S15
  • [3] Cardiovascular disease risk stratification in type 2 diabetes
    Esdaile, Harriet
    Mayet, Jamil
    Hill, Neil
    [J]. DIABETIC MEDICINE, 2022, 39 (10)
  • [4] Risk Prediction of Cardiovascular Disease in Type 2 Diabetes
    Cederholm, Jan
    Eeg-Olofsson, Katarina
    Eliasson, Bjoern
    Zethelius, Bjoern
    Nilsson, Peter M.
    Gudbjornsdottir, Soffia
    [J]. DIABETES CARE, 2008, 31 (10) : 2038 - 2043
  • [5] Use of focus groups to develop methods to communicate cardiovascular disease risk and potential for risk reduction to people with type 2 diabetes
    Price, Hermione C.
    Dudley, Christina
    Barrow, Beryl
    Kennedy, Ian
    Griffin, Simon J.
    Holman, Rury R.
    [J]. FAMILY PRACTICE, 2009, 26 (05) : 351 - 358
  • [6] Dairy products and cardiovascular risk
    Lecerf, Jean-Michel
    [J]. CAHIERS DE NUTRITION ET DE DIETETIQUE, 2010, 45 (01): : 18 - 26
  • [7] Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease
    Shiroma, Eric J.
    Cook, Nancy R.
    Manson, Joann E.
    Moorthy, M. V.
    Buring, Julie E.
    Rimm, Eric B.
    Lee, I-Min
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2017, 49 (01): : 40 - 46
  • [8] Update on Type 2 Diabetes as a Cardiovascular Disease Risk Equivalent
    Kuusisto, Johanna
    Laakso, Markku
    [J]. CURRENT CARDIOLOGY REPORTS, 2013, 15 (02)
  • [9] Awareness of Cardiovascular Disease Risk in People with Type 2 Diabetes
    Imrisek, Steven D.
    Hoy-Rosas, Jamillah R.
    Lavaysse, Lindsey M.
    Lee, Matthew
    Dachis, Jeff
    Sears, Lindsay
    [J]. DIABETES, 2022, 71
  • [10] Cardiovascular disease risk in patients with type 2 diabetes and hypertension
    Kawada, Tomoyuki
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 (02)